Table 5 Univariate and multivariate Cox regression for OS of stage I–II

Age

486

1.150 (1.095–1.207)

 < 0.001

1.142 (1.078–1.210)

 < 0.001

BMI

197

1.117 (0.974–1.280)

0.114

Chemotherapy

486

0.401

 No

257

Reference

 Yes

229

0.696 (0.297—1.634)

0.405

Radiotherapy

486

0.071

 No

422

Reference

Reference

 Yes

64

2.551 (0.998–6.520)

0.050

1.382 (0.478–3.998)

0.550

Myometrial infiltration (> = 1/2)

486

0.003

 No

369

Reference

Reference

 Yes

83

4.721 (2.003–11.131)

 < 0.001

3.316 (1.075–10.230)

0.037

 Unknown

34

1.193 (0.152–9.342)

0.866

0.857 (0.089–8.284)

0.894

Cervix involvement

486

0.061

 No

421

Reference

Reference

 Yes

22

3.994 (1.155–13.810)

0.029

1.657 (0.392–7.011)

0.493

 Unknown

43

2.773 (0.917–8.391)

0.071

4.522 (0.961–21.270)

0.056

Lymph node metastasis

486

0.106

 Unknown

86

Reference

 No

400

0.457 (0.186–1.121)

0.087

Pathological type

486

 < 0.001

 UEC

367

Reference

Reference

 UCCC

23

9.390 (2.878–30.641)

 < 0.001

4.799 (1.121–20.546)

0.035

USC

66

6.059 (2.332–15.745)

 < 0.001

2.996 (0.852–10.529)

0.087

 UMC

30

1.719 (0.217–13.618)

0.608

2.493 (0.278–22.353)

0.414